This is the most up-to-date market report focusing on Cellular
Therapy and the HSCT/Cord Blood Market Landscape, published by Select
Biosciences. In this comprehensive market report, we have focused
primarily on quantitative market metrics in order to characterize the
growth and evolution of the cellular therapy field--in this vein, we
present primary industry data that Select Biosciences has collected as
part of its continual industry tracking of this space.
We've analyzed clinical trial trends and the evolution of several
therapeutics areas within cellular therapy [orthopedic, skin/wound care,
cardiovascular, and CNS disorders] and present the current status of
every single program within the preclinical through the various clinical
trial phases and onto commercialization. We also present the breakout
of clinical trials in the bona fide cellular therapy sector with respect
to geographic breakout, breakout by type of cells utilized, and disease
classes interrogated.
To Buy The Copy Of This Report Visit: http://www.industrymonitor.co/report/160812-cellular
Select Biosciences has also provided a detailed quantitative
analysis of the cord blood field as it is rapidly evolving. Our
coverage provides hard numbers on sizes of the various registries, the
TNC breakouts of banked units, detailed cost breakouts for banking as
well as HSCTs utilizing cord blood. Furthermore, given our global
footprint, we've been able to compare the EU and US markets side-by-side
in this analysis.
Select Biosciences also presents the ATMP regulatory guidelines
governing the marketing authorization of cellular therapeutics in the
European Union. Details on the statute as well as implications to
companies seeking to navigate this space are provided.
For All Market Reports Kindly visit: http://www.industrymonitor.co/
Extensive Market Analyses
Presented in this Report
- Regenerative Medicine and Stem Cell Research Activity in the US
- Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
- Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
- Breakout of Spending by Product Platforms in Various Spaces
- Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
- Autologous vs. Allogeneic Cellular Therapy: Industry SWOT
- Adult Stem Cell Therapy Quantitative Market Forecast
- Cellular Therapy Product Pipeline
- Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
- HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
- Indications for HSCTs in North America: Disease Classes Addressed, Age of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
- Cost Analyses of HSCTs in the EU vs. US Markets
- Cord Blood Banking Quantitative Market Metrics
- Growth of BM, PBL, and CB Units Worldwide in Public Banks and Registries, Segmented by Country
- Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
- EU and US Cord Blood Transplantation Detailed Cost Breakouts
- EU ATMP Regulation Detailed Analysis
- Stem Cells Worldwide Publications Analysis
0 comments:
Post a Comment
Note: only a member of this blog may post a comment.